San Francisco startup Structure Therapeutics is also working on an oral, as soon as-daily GLP-one drug identified as GSBR-1290—the drug surpassed Wall Avenue’s expectations in June any time a mid-phase research showed ordinary weight loss of close to 6% and it options to start out An